Private Capital Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Private Capital Group’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-523	Closed	-$10K	–	2346
2018 Q1	$10K	Sell	523 -1,933	-79%	-$37.9K	﹤0.01%	1389
2017 Q4	$8	Buy	+2,456	New	+$45K	﹤0.01%	1490

Private Capital Group's IPXL Position: Q2 2018 in Review

Private Capital Group sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 523 shares — an estimated $10K sold.

Private Capital Group first reported a position in IPXL in Q4 2017 and held it in 2 quarters. The position peaked at $10K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Private Capital Group reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Private Capital Group sold 523 Impax Laboratories, Inc. shares in Q2 2018, an estimated $10K.
Private Capital Group first reported a position in Impax Laboratories, Inc. in Q4 2017 and held it in 2 quarters.
Private Capital Group's Impax Laboratories, Inc. position peaked at $10K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Private Capital Group's 13F filing for Q2 2018, filed 9 Aug 2018.